Roche first-quarter sales up

Roche expects "mid to high" single digit growth to continue in 2002 Keystone

Pharmaceutical group Roche has announced a six per cent rise in first-quarter sales to SFr7.37 billion.

This content was published on April 16, 2002 - 09:45

The company expects mid to high single digit growth to continue for the remainder of the year.

Sales in Roche's drug division rose five percent, when expressed in Swiss francs, while its diagnostics businesses yielded 9 percent.

Franz Humer, Roche's CEO, rejected speculation that the company was preparing a merger with drug giant Novartis.

swissinfo with agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.